CSE1L and esophageal squamous cell carcinoma: We preliminarily confirmed the involvement of CSE1L in the effects of FLVCR1 on the cellular proliferation and migration of ESCC, indicating that FLVCR1-targeting treatment may be promising in the therapies of patients with ESCC.